Profile:

Heel is an internationally operating company that develops, produces and markets homoeopathic combination remedies. In 2009, Biologische Heilmittel Heel GmbH, headquartered in Baden-Baden, Germany, had 1,300 employees and posted sales worth 173m Euros – 70 percent in markets outside Germany. Heel operates subsidiaries in Belgium, Brazil, Chile, Canada, Colombia, the Netherlands, Poland, Spain, the Republic of South Africa and the USA. Heel products are available in a total of 56 countries across the globe through various distribution partners.
For more information, visit www.heel.de / www.heel.com.

Project description: We support Heel with the coordination, expansion and implementation of international PR to raise the company’s profile.

Project start: October 2010

News:

November 23, 2011
Research supports Multitarget Approach to Alzheimer's
Heel at Neuroscience 2011: Preclinical Studies indicate symptom and disease modifying effect of a natural complex medication ...more
...Spanish version

October 12, 2011
Treating Sports Injuries Naturally and Evidence-based
Heel: Experiences and Trials on Biological Multi-Target Medication prove Inflammation-Modulating Efficacy ...more

October 10, 2011
Heel Pioneers with Genome Research at ECIM
Next Generation Genome Sequencing Inflames Discussion on Multi-Target Approach and Bioregulatory Medicine ...more

Archive